Inflazyme Pharmaceuticals (Research & Development assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Inflazyme Pharmaceuticals (Research & Development assets) General Information

Description

Portfolio of biotechnological research and development programs and assets. The assets included programs on the LSAIDs, the PDE inhibitors and the Protein Therapeutics Technology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Montreal, Quebec
  • Canada
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Montreal, Quebec
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inflazyme Pharmaceuticals (Research & Development assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Inflazyme Pharmaceuticals (Research & Development assets)‘s full profile, request access.

Request a free trial

Inflazyme Pharmaceuticals (Research & Development assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Inflazyme Pharmaceuticals (Research & Development assets)‘s full profile, request access.

Request a free trial

Inflazyme Pharmaceuticals (Research & Development assets) FAQs

  • Where is Inflazyme Pharmaceuticals (Research & Development assets) headquartered?

    Inflazyme Pharmaceuticals (Research & Development assets) is headquartered in Montreal, Canada.

  • What industry is Inflazyme Pharmaceuticals (Research & Development assets) in?

    Inflazyme Pharmaceuticals (Research & Development assets)’s primary industry is Buildings and Property.

  • Is Inflazyme Pharmaceuticals (Research & Development assets) a private or public company?

    Inflazyme Pharmaceuticals (Research & Development assets) is a Private company.

  • What is the current valuation of Inflazyme Pharmaceuticals (Research & Development assets)?

    The current valuation of Inflazyme Pharmaceuticals (Research & Development assets) is .

  • What is Inflazyme Pharmaceuticals (Research & Development assets)’s current revenue?

    The current revenue for Inflazyme Pharmaceuticals (Research & Development assets) is .

  • Who are Inflazyme Pharmaceuticals (Research & Development assets)’s investors?

    EACOM Timber has invested in Inflazyme Pharmaceuticals (Research & Development assets).

  • When was Inflazyme Pharmaceuticals (Research & Development assets) acquired?

    Inflazyme Pharmaceuticals (Research & Development assets) was acquired on 19-Nov-2007.

  • Who acquired Inflazyme Pharmaceuticals (Research & Development assets)?

    Inflazyme Pharmaceuticals (Research & Development assets) was acquired by Biolipox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process